These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 22788968
1. The therapeutic potential of 5-HT1A receptors: a patent review. Lacivita E, Di Pilato P, De Giorgio P, Colabufo NA, Berardi F, Perrone R, Leopoldo M. Expert Opin Ther Pat; 2012 Aug; 22(8):887-902. PubMed ID: 22788968 [Abstract] [Full Text] [Related]
2. 5-HT(1A) receptor: an old target as a new attractive tool in drug discovery from central nervous system to cancer. Fiorino F, Severino B, Magli E, Ciano A, Caliendo G, Santagada V, Frecentese F, Perissutti E. J Med Chem; 2014 Jun 12; 57(11):4407-26. PubMed ID: 24295064 [Abstract] [Full Text] [Related]
3. 5-HT1A receptor ligands and their therapeutic applications: review of new patents. Staroń J, Bugno R, Hogendorf AS, Bojarski AJ. Expert Opin Ther Pat; 2018 Sep 12; 28(9):679-689. PubMed ID: 30124346 [Abstract] [Full Text] [Related]
9. Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease. Ohno Y. CNS Neurosci Ther; 2011 Feb 15; 17(1):58-65. PubMed ID: 21091640 [Abstract] [Full Text] [Related]
10. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors. Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L. J Med Chem; 2012 Jan 12; 55(1):23-36. PubMed ID: 22145629 [Abstract] [Full Text] [Related]
11. Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. Mor M, Rivara S, Pala D, Bedini A, Spadoni G, Tarzia G. Expert Opin Ther Pat; 2010 Aug 12; 20(8):1059-77. PubMed ID: 20533893 [Abstract] [Full Text] [Related]
14. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities. Youn J, Misane I, Eriksson TM, Millan MJ, Ogren SO, Verhage M, Stiedl O. Neuropharmacology; 2009 Aug 12; 57(5-6):567-76. PubMed ID: 19607850 [Abstract] [Full Text] [Related]
15. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. Liégeois JF, Deville M, Dilly S, Lamy C, Mangin F, Résimont M, Tarazi FI. J Med Chem; 2012 Feb 23; 55(4):1572-82. PubMed ID: 22268448 [Abstract] [Full Text] [Related]
19. Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins. Byrtus H, Pawłowski M, Czopek A, Bojarski AJ, Duszyńska B, Nowak G, Kłodzińska A, Tatarczyńska E, Wesołowska A, Chojnacka-Wójcik E. Eur J Med Chem; 2005 Aug 23; 40(8):820-9. PubMed ID: 16122584 [Abstract] [Full Text] [Related]